相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers
Cinzia Tesauro et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
Giuseppe Tonini et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
D. C. Gilbert et al.
BRITISH JOURNAL OF CANCER (2012)
DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets
M. Alagoz et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Therapeutic strategies in epithelial ovarian cancer
Ayako Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer
Ying Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Y-box-binding protein 1 (YB-1) and its functions
I. A. Eliseeva et al.
BIOCHEMISTRY-MOSCOW (2011)
DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents
Annamaria Biroccio et al.
CLINICAL CANCER RESEARCH (2011)
Y-box binding protein-1 is a novel molecular target for tumor vessels
Mayu Takahashi et al.
CANCER SCIENCE (2010)
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells
Yuji Basaki et al.
EUROPEAN JOURNAL OF CANCER (2010)
Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
Masaki Shiota et al.
CANCER RESEARCH (2009)
DNA topoisomerase II and its growing repertoire of biological functions
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity
Anindya Goswami et al.
CANCER RESEARCH (2008)
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Anju Singh et al.
CANCER RESEARCH (2008)
The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells
David Guay et al.
CANCER SCIENCE (2008)
Twist and p53 reciprocally regulate target genes via direct interaction
M. Shiota et al.
ONCOGENE (2008)
Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topolsomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death
Agneyo Ganguly et al.
CANCER RESEARCH (2007)
Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress
Soumita Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional interactions of DNA topoisomerases with a human replication origin
Gulnara Abdurashidova et al.
EMBO JOURNAL (2007)
Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex
N. Sen et al.
CELL DEATH AND DIFFERENTIATION (2007)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Some p53-binding proteins that can function as arbiters of life and death
A. W. Braithwaite et al.
CELL DEATH AND DIFFERENTIATION (2006)
Gefitinib (Iressa, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells
O Kishida et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Proteomic analysis of complexes formed by human topoisomerase I
A Czubaty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AEF release
MT Park et al.
BLOOD (2005)
Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death
P Daroui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani
N Sen et al.
CELL DEATH AND DIFFERENTIATION (2004)
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms -: Intermediacy of H2O2- and p53-dependent pathways
SW Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination
L Ferrara et al.
NUCLEIC ACIDS RESEARCH (2004)
YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins
I Gaudreault et al.
NUCLEIC ACIDS RESEARCH (2004)
DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation
HL Huang et al.
ONCOGENE (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1
K Kohno et al.
BIOESSAYS (2003)
E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin
YB Dong et al.
CANCER GENE THERAPY (2003)
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies
M Kuwano et al.
CANCER SCIENCE (2003)
p73 interacts with c-Myc to regulate Y-box-binding protein-1 expression
H Uramoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ROS, stress-activated kinases and stress signaling in cancer
M Benhar et al.
EMBO REPORTS (2002)
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′→5′ exonuclease activity
H Izumi et al.
NUCLEIC ACIDS RESEARCH (2001)
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression
T Okamoto et al.
ONCOGENE (2000)
分享论文
